BiotechTube
Home/Renovion/Derek Winstanly, MBChB
DW

Derek Winstanly, MBChB

Chairman of the Board

Renovion

Therapeutic Areas

PulmonologyTransplant Medicine

Renovion Pipeline

DrugIndicationPhase
ARINA-1 (RVN-301)Non-Cystic Fibrosis Bronchiectasis (NCFBE)Phase 2

Leadership Team at Renovion

DC
Dan Copeland
Chief Executive Officer
CD
Carolyn Durham, PhD
Chief Scientific Officer
MZ
Marty Zamora, MD
Chief Medical Officer
MT
Marilyn Thompson
Head of Finance
HC
Hal Craig
Head of Chemistry, Manufacturing, and Controls Strategy and Operations
View full Renovion profile